Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | ALK |
| Variant | F1174S |
| Impact List | missense |
| Protein Effect | gain of function |
| Gene Variant Descriptions | ALK F1174S lies within the protein kinase domain of the Alk protein (UniProt.org). F1174S results in ligand-independent activation of the Alk protein and increased Erk phosphorylation in culture (PMID: 21059859), activation in an in vitro assay (PMID: 33674381), and transformation of cells in culture (PMID: 21059859, PMID: 33674381, PMID: 29084134). |
| Associated Drug Resistance | |
| Category Variants Paths |
ALK mutant ALK act mut ALK F1174S ALK mutant ALK F1174X ALK F1174S |
| Transcript | NM_004304.5 |
| gDNA | chr2:g.29220830A>G |
| cDNA | c.3521T>C |
| Protein | p.F1174S |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| NM_004304.5 | chr2:g.29220830A>G | c.3521T>C | p.F1174S | RefSeq | GRCh38/hg38 |
| NM_004304.4 | chr2:g.29220830A>G | c.3521T>C | p.F1174S | RefSeq | GRCh38/hg38 |
| NM_004304 | chr2:g.29220830A>G | c.3521T>C | p.F1174S | RefSeq | GRCh38/hg38 |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|---|---|---|---|---|---|---|
| ALK F1174S | Advanced Solid Tumor | predicted - sensitive | TPX-0131 | Preclinical - Biochemical | Actionable | In a preclinical study, TPX-0131 inhibited kinase activity of ALK F1174S in an in vitro assay (PMID: 34158340). | 34158340 |